|
一、英文文獻(採用APA格式第七版) 1.Arabi, Y. M., Mandourah, Y., Al-Hameed, F., Sindi, A. A.,Almekhlafi, G. A., Hussein,M. A., Jose, J., Pinto, R., Al-Omari, A., & Kharaba, A. (2018). Corticosteroid Therapy for Critically ill Patients with Middle East Respiratory Syndrome.American Journal of Respiratory and Critical Care Medicine, 197(6), 757-767. 2.Birihane, B. M., Bayih, W. A., Alemu, A. Y., & Belay, D. M. (2020). Perceived Barriers and Preventive Measures of COVID-19 Among Healthcare Providers in Debretabor, North Central Ethiopia, 2020. Risk Management and Healthcare Policy, 13, 2699. 3.Blot, K., Bergs, J., Vogelaers, D., Blot, S., & Vandijck, D. (2014). Prevention of Central Line–Associated Bloodstream Infections Through Quality Improvement Interventions: A Systematic Review and Meta-analysis. Clinical Infectious Diseases, 59(1), 96-105. 4.Control, C. f. D., & Prevention. (2020). CDC-Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings-NIOSH Workplace Safety and Health Topic. US Dep Heal Hum Serv [Internet], 4-9. 5.D'Adamo, H., Yoshikawa, T., & Ouslander, J. G. (2020). Coronavirus Disease 2019 in Geriatrics and Long‐Term Care: the ABCDs of COVID‐19. Journal of the American Geriatrics Society, 68(5), 912-917. 6.De Angelis, G., Cataldo, M. A., De Waure, C., Venturiello, S., La Torre, G., Cauda, R., Carmeli, Y., & Tacconelli, E. (2014). Infection Control and Prevention Measures to Reduce the Spread of Vancomycin-Resistant Enterococci in Hospitalized Patients: A Systematic Review and Meta-analysis. Journal of Antimicrobial Chemotherapy, 69(5), 1185-1192. 7.Eriksen, H., Koch, A., Elstrøm, P., Nilsen, R., Harthug, S., & Aavitsland, P. (2007).Healthcare-associated Infection Among Residents of Long-Term Care Facilities:A Cohort and Nested Case–Control Study. Journal of Hospital Infection, 65(4), 334-340. 8.Gautret, P., Lagier, J.-C., Parola, P., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., & Dupont, H. T. (2020). Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial. International Journal of Antimicrobial Agents, 56(1), 105949. 9.Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., & Lescure, F.-X. (2020). Compassionate Use of Remdesivir for Patients with Severe COVID-19. New England Journal of Medicine, 382(24), 2327-2336. 10.Guan, W.-j., Ni, Z.-y., Hu, Y., Liang, W.-h., Ou, C.-q., He, J.-x., Liu, L., Shan, H., Lei, C.-l., & Hui, D. S. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382(18), 1708-1720. 11.Harrington, C., Kovner, C., Mezey, M., Kayser-Jones, J., Burger, S., Mohler, M., Burke, R., & Zimmerman, D. (2000). Experts Recommend Minimum Nurse Staffing Standards for Nursing Facilities in the United States. Gerontologist, 40(1), 5-17. 12.He, X., Lau, E. H., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., & Tan, X. (2020). Temporal Dynamics in Viral Shedding and Transmissibility of COVID-19. Nature Medicine, 26(5), 672-675. 13.Hsu, Y.-C., Chen, Y.-L., Wei, H.-N., Yang, Y.-W., & Chen, Y.-H. (2017). Risk and Outbreak Communication: Lessons From Taiwan's Experiences in the Post-SARS Era. Health Security, 15(2), 165-169. 14.Hugonnet, S., Harbarth, S., Sax, H., Duncan, R. A., & Pittet, D. (2004). Nursing Resources: A Major Determinant of Nosocomial Infection. Current Opinion in Infectious Diseases, 17(4), 329-333. 15.Lee, M. H., Lee, G. A., Lee, S. H., & Park, Y.-H. (2020). A Systematic Review on the Causes of the Transmission and Control Measures of Outbreaks in long-Term Care Facilities: Back to Basics of Infection Control. PLoS One, 15(3), e0229911. 16.Michaels, C. (1992). Carondelet St. Mary's Nursing Enterprise. The Nursing Clinics of North America, 27(1), 77-85. 17.Mulangu, S., Dodd, L. E., Davey Jr, R. T., Tshiani Mbaya, O., Proschan, M., Mukadi, D., Lusakibanza Manzo, M., Nzolo, D., Tshomba Oloma, A., & Ibanda, A. (2019). A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. New England Journal of Medicine, 381(24), 2293-2303. 18.Organization, W. H. (2019). Clinical Management of Severe Acute Respiratory Infection when Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection is Suspected: Interim Guidance. 19.Prabhakaran, S., Doraiswamy, V. A., Nagaraja, V., Cipolla, J., Ofurum, U., Evans, D. C., Lindsey, D. E., Seamon, M. J., avuturu, S. K., Gerlach, A. T., Jaik, N. P., Eiferman, D. S., Papadimos, T. J., Adolph, M. D., Cook, C. H., Stawicki, S. P. A. (2012) .Nasoenteric Tube Complications. Scandinavian Journal of Surgery, 101,147-155. 20.Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020). Baricitinib as Potential Treatment for 2019-nCoV Acute Respiratory Disease. Lancet (London, England), 395(10223), e30- e31. 21.Rolland, Y., Lacoste, M.-H., De Mauleon, A., Ghisolfi, A., Barreto, P. D. S., Blain, H., & Villars, H. (2020). Guidance for the Prevention of the COVID-19 Epidemic in Long-Term Care Facilities: A Short-Term Prospective Study. The Journal of Nutrition, Health & Aging, 24(8), 812-816. 22.Rothan, H. A., & Byrareddy, S. N. (2020). The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. Journal of Autoimmunity, 109, 102433. 23.Ruffy, F., Wang, T., & Sivaraman, A. (2020). Gauntlet: Finding Bugs in Compilers for Programmable Packet Processing. USENIX Association, Virtual Online. https://www.usenix.org/conference/osdi20/presentation/ruffy 24.Smith, P. W., Bennett, G., Bradley, S., Drinka, P., Lautenbach, E., Marx, J., Mody, L., Nicolle, L., & Stevenson, K. (2008). SHEA/APIC Guideline: Infection Prevention and Control in the Long-Term Care Facility. Infection Control & Hospital Epidemiology, 29(9), 785-814. 25.Spector, W. D., & Takada, H. A. (1991). Characteristics of Nursing Homes that Affect Resident Outcomes. Journal of Aging and Health, 3(4), 427-454. 26.Velavan, T. P., & Meyer, C. G. (2020). The COVID‐19 Epidemic. Tropical Medicine & International Health, 25(3), 278-280. 27.Van Seventer, J. M., & Hochberg, N. S. (2017). Principles of Infectious Diseases: Transmission, Diagnosis, Prevention, and Control. International Encyclopedia of Public Health, 2(6), 22-39. 28.Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020). A Novel Coronavirus Outbreak of Global Health Concern. The Lancet, 395(10223), 470-473. 29.Wang, C. J., Ng, C. Y., & Brook, R. H. (2020). Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. Jama, 323(14),1341-1342. 30.Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in Vitro. Cell Research, 30(3), 269-271. 31.Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., & Lu, Q. (2020). Remdesivir in Adults with Severe COVID-19: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial. The Lancet, 395(10236),1569-1578. 32.World Health Organization. (2020). Modes of Transmission of Virus Causing COVID-19: Implications for IPC Precaution Recommendations. https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-COVID-19-implications-for-ipc-precaution-recommendations. 33.World Health Organization. (2009) . Hand Hygiene in Outpatient and Homebased Care and Long-Term Care Facilities. Available. https://www.who.int/gpsc/5may/hh_guide.pdf 34.Yen, M.-Y., Lin, Y.-E., Lee, C.-H., Ho, M.-S., Huang, F.-Y., Chang, S.-C., & Liu, Y.- C. (2011). Taiwan's Traffic Control Bundle and The Elimination of Nosocomial Severe Acute Respiratory Syndrome Among Healthcare Workers. Journal of Hospital Infection, 77(4), 332-337.
二、中文文獻 1.王雲東(2006).台灣地區中老年與老年人醫療服務使用率的影響因素研究.健 康城市學刊,4,141-163。 2.王映雪、吳麗蘭、盧美秀(2014).不同訓練方式對長照機構服務員感控認知之 成效.北市醫學雜誌,11(3),73-85。 3.台灣長期照護專業協會(2003).中華民國長期照護專業協會長期照護雜誌投稿 原則.長期照護雜誌,7(1),84-85。 4.朱凱莙、張國基(2020).醫院新型冠狀病毒 (COVID-19) 防疫感染管制與風險 評估措施.工業安全衛生,371,9-28。 5.吳孟嬪、陳亮恭、黃信彰、高木榮(2008).養護機構個案整合醫療服務模式之 成效.北市醫學雜誌,5(5),524-534。 6.吳仁光、惠群(2013) .護理之家肺炎的臨床特性.內科學誌,24(2),107-117。 7.李允吉、劉建衛(2010).導尿管相關的菌尿和尿路感染.感染控制雜誌,20(3),163-172。 8.李孟羲、江蕙娟、胡月娟(2008).長期照顧機構照護品質監測指標之變革.長 期照護雜誌,12(1),32-41。 9.周麟如、李雅欣(2015).以感染鍊的觀點談預防呼吸機相關性肺炎之護理.領 導護理,16(3),34-43。 10.林月桂、顏慕庸(2020).長照機構因應新冠肺炎全球大流行之整備.醫療品質 雜誌,14(3),11-15。 11.林建志、鄭秀津、蘇永裕、鍾蝶起(2011).高雄地區長期照護機構住民醫療服 務使用情形及其相關因素探討.美和學報,35(1),143-158。 12.林永捷、彭莉甯、陳亮恭(2011).長期照護機構住民的感染症.台灣老年醫學 暨老年學雜誌,6(2),73-85。 13.劉震龍、翁夢璐、林秀玉(2008).介紹『以人為本』概念彙整之感染控制架構.感染控制雜誌,18(1),47-55。 14.施玉燕、柯玉芬、曾淑慧(2018).2016年度長期照護機構感染管制查核報告. 疫情報導,34(5),75-81。 15.國家實驗研究院科技政策研究與資訊中心(2021年10月08日).政策研究指標 資料庫。區自:https://pride.stpi.narl.org.tw/index/graph-world/detail/4b1141ad70bfda5f0170e64424db3fa3 16.張珠玲、陳昶華(2015).護理之家感染管制的執行現況探討.感染控制雜誌, 25(3),115-125。 17.張淑卿、許銘能、吳肖琪(2010).台灣長期照護機構品質確保機制發展之趨 勢.長期照護雜誌,14(2),149-159。 18.張雅媛、顧文瑋、林志陵、陳冠仰、蕭勝煌(2020).COVID-19 全球流行時的 契機: 感染管制之轉變與創新.北市醫學雜誌,17(4),390-401。 19.王凱淞、張時獻(2018).簡明傳染病學(第三版).新文京。 20.邱文誼、李德芬、黃翌庭(2018).一位社區型肺炎合併氣切造口老人之護理經 驗.嘉基護理,18(1),14-24。 21.張筱玲、曾淑貞、郭易冰、曾淑慧(2016).臺灣長期照護機構感染管制問題分 析與政策.疫情報導,32(1),10-17。 22.盛望徽(2020).新型冠狀病毒感染症.內科學誌,31(2),61-66。 23.陳抱宇、盛望徽(2020).流感之疫苗預防.內科學誌,31(1),7-10. 24.陳郁慧(2019).長照機構未來的感染管制趨勢.醫療品質雜誌,13(4),76-79。 25.陳綾穗、郭彥宏、陳惠貞(2018).運用 Andersen 醫療服務行為模式探討醫療 資源豐富程度對跨區醫療利用行為之影響.南臺灣醫學雜誌,14(2),72-81。 26.黃美凰、李秀春、宋玉貞(2012年12月26日).長期照護機構照顧品質之探 討.美和科技大學護理系.取自: http://ir.meiho.edu.tw/handle/987654321/1981 27.黃淑如、陳郁慧、姜秀子、吳怡慧、吳麗鴻、林均穗、施智源、盧敏吉、薛博 仁(2017).老人福利機構(長期照顧機構及安養機構)之感染管制與查核準 備建議.感染控制雜誌,27(2),59-70。 28.廖永澄、呂淑華(2014).以實證探討鼻胃管灌食導致吸入性肺炎之預防措施. 長期照護雜誌,18(2),237-250。 29.臧麗琳、楊俊郎、黃璉華、郭英調(2004).護理之家感染盛行率調查及感染管 制現況.長期照護雜誌,8(4),425-439。 30.衛生福利部中央健康保險署(2021,8月05日)。2020年國人全民健康保險就 醫疾病資訊。取自: https://www.nhi.gov.tw/Content_List.aspx?n=D529CAC4D8F8E77B&topn =23C660CAACAA159D 31.衛生福利部疾病管制署(2020,4月07日)。矯正機關因應 COVID-19(武漢肺 炎)感染管制措施指引。取自: https://www.cdc.gov.tw/File/Get/Z6Yt8C003yW6hd9324tstw 32.衛生福利部疾病管制署(2020,05月51日)。「COVID‐19(武漢肺炎)」阻絕 社區傳染策略 阻絕社區傳染策略 阻絕社區傳染策略。取自: https://www.cdc.gov.tw/File/Get/BCqM2STbY67hX2VXzTwjxg 33.衛生福利部疾病管制署(2018,12月21日)。傳染病統計暨監視年報-106年 (中文)_1221.pdf。取自: https://www.cdc.gov.tw/File/Get/YAsWS9-gfzM885GPVlqyig 34.衛生福利部疾病管制署(2020)。為加強 COVID-19(武漢肺炎)監測,指揮中 心修訂嚴重特指揮中心修訂嚴重特殊傳染性肺炎病例定義, 殊傳染性肺 炎病例定義,並擴大社區監測採檢對象 並擴大社區監測採檢對象 並擴大 社區監測採檢對象。取自: https://www.cdc.gov.tw/Bulletin/Detail/hlaLHKBP91j9VUy0kc2f_A?ty peid=9 35.衛生福利部疾病管制署(2020)。國內檢驗總計。取自: https://www.cdc.gov.tw/ 36.衛生福利部疾病管制署(2020)。醫療機構因應嚴重特殊傳染性肺炎感染管制措 施指引醫療機構因應嚴重特殊傳染性肺炎感染管制措施指引 醫療機構因 應嚴重特殊傳染性肺炎感染管制措施指引。取自: https://www.cdc.gov.tw/Category/ListContent/NO6oWHDwvVfwb2sbWzvH WQ? uaid=UDXo5Wd2jDnm__vJUU9PjQ 37.盧榮和、周青青(2016).藥物臨床試驗保險之研究–受試者保護觀點.保險專 刊,32(2),183-216。 38.賴建丞(2020).針對新型冠狀病毒流行病的風險評估-以研究機構為例.工業安 全衛生,371,29-40。 39.聯合新聞網(2020年3月22日)。長照護理師確診53住民連夜移出。取自: https://udn.com/news/story/120940/4435431
|